Ou, Y., Cui, Z., Lou, S., Zhu, C., Chen, J., Zhou, L., . . . Zou, F. (2024). Analysis of tirzepatide in the US FDA adverse event reporting system (FAERS). Frontiers in Pharmacology, 15, . https://doi.org/10.3389/fphar.2024.1463657
Chicago Style (17th ed.) CitationOu, Yingyong, Zhiwei Cui, Siyu Lou, Chengyu Zhu, Junyou Chen, Linmei Zhou, Ruizhen Zhao, Li Wang, and Fan Zou. "Analysis of Tirzepatide in the US FDA Adverse Event Reporting System (FAERS)." Frontiers in Pharmacology 15 (2024). https://doi.org/10.3389/fphar.2024.1463657.
MLA (9th ed.) CitationOu, Yingyong, et al. "Analysis of Tirzepatide in the US FDA Adverse Event Reporting System (FAERS)." Frontiers in Pharmacology, vol. 15, 2024, https://doi.org/10.3389/fphar.2024.1463657.